Teva Pharmaceutical Industries reported $1.16B in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Aspen Pharmacare ZAR 444.02M 0 Dec/2025
Cipla INR 807.78M 17K Mar/2026
Dr.Reddys Laboratories INR 832.69M 176K Mar/2026
Guangzhou Baiy CNY 1.63B 0 Dec/2025
Jiangsu Hengrui CNY 6.64B 0 Mar/2026
Kalbe Farma IDR 45.32B 77.26M Sep/2025
Richter Gedeon HUF 182.86M 3.51M Mar/2026
Sh Fosun Pharma CNY 2.67B 0 Dec/2025
Sun Pharmaceuticals INR 2.4B 0 Mar/2026
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026